Zobrazeno 1 - 10
of 774
pro vyhledávání: '"Tae-You Kim"'
Autor:
Jeayeon Park, Yun Bin Lee, Yunmi Ko, Youngsu Park, Hyunjae Shin, Moon Haeng Hur, Min Kyung Park, Dae-Won Lee, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Tae-Yong Kim, Yoon Jun Kim, Tae-You Kim, Jung-Hwan Yoon
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 1, Pp 81-91 (2024)
Background/Aim Atezolizumab plus bevacizumab and lenvatinib are currently available as first-line therapy for the treatment of unresectable hepatocellular carcinoma (HCC). However, comparative efficacy studies are still limited. This study aimed to i
Externí odkaz:
https://doaj.org/article/0fba6f18253441e3be10280165c026e9
Autor:
Su Yeon Kim, Seongmun Jeong, Wookjae Lee, Yujin Jeon, Yong-Jin Kim, Seowoo Park, Dongin Lee, Dayoung Go, Sang-Hyun Song, Sanghoo Lee, Hyun Goo Woo, Jung-Ki Yoon, Young Sik Park, Young Tae Kim, Se-Hoon Lee, Kwang Hyun Kim, Yoojoo Lim, Jin-Soo Kim, Hwang-Phill Kim, Duhee Bang, Tae-You Kim
Publikováno v:
Experimental and Molecular Medicine, Vol 55, Iss 11, Pp 2445-2460 (2023)
Abstract Cell-free DNA (cfDNA) sequencing has demonstrated great potential for early cancer detection. However, most large-scale studies have focused only on either targeted methylation sites or whole-genome sequencing, limiting comprehensive analysi
Externí odkaz:
https://doaj.org/article/e7b67327da5a4e4296ba9a2fb35e955f
Publikováno v:
Ultrasonography, Vol 42, Iss 3, Pp 457-465 (2023)
Purpose The aim of this study was to assess the role of the shear-wave velocity (SWV) value in predicting chemotherapeutic response and progression-free survival (PFS) in patients with colorectal cancer liver metastasis (CRLM). Methods In this prospe
Externí odkaz:
https://doaj.org/article/7d1af8da29be4e1f88d3aef82d4fd71b
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background A growing body of research has emphasized 5-hydroxymethylcytosine (5hmC) as an important epigenetic mark. High-resolution methods to detect 5hmC require high sequencing depth and are therefore expensive. Many studies have used enr
Externí odkaz:
https://doaj.org/article/bd98b4d2189444af975f006d2dab5545
Autor:
Kyukwang Kim, Mooyoung Kim, Andrew J. Lee, Sang-Hyun Song, Jun-Kyu Kang, Junghyun Eom, Gyeong Hoon Kang, Jeong Mo Bae, Sunwoo Min, Yeonsoo Kim, Yoojoo Lim, Han Sang Kim, Young-Joon Kim, Tae-You Kim, Inkyung Jung
Publikováno v:
Cell Reports, Vol 42, Iss 7, Pp 112778- (2023)
Summary: The regulatory effect of non-coding large-scale structural variations (SVs) on proto-oncogene activation remains unclear. This study investigated SV-mediated gene dysregulation by profiling 3D cancer genome maps from 40 patients with colorec
Externí odkaz:
https://doaj.org/article/a5326d36caf94f26bc6e0a3fe2b60e45
Autor:
Young‐Won Cho, Dong‐Wook Min, Hwang‐Phill Kim, Yohan An, Sheehyun Kim, Jeonghwan Youk, Jaeyoung Chun, Jong Pil Im, Sang‐Hyun Song, Young Seok Ju, Sae‐Won Han, Kyu Joo Park, Tae‐You Kim
Publikováno v:
Molecular Oncology, Vol 16, Iss 12, Pp 2396-2412 (2022)
Patient‐derived organoids are being considered as models that can help guide personalized therapy through in vitro anticancer drug response evaluation. However, attempts to quantify in vitro drug responses in organoids and compare them with respons
Externí odkaz:
https://doaj.org/article/11f7fe63d5334fa3933c273c28144f06
Autor:
Yoojoo Lim, Sheehyun Kim, Jun-Kyu Kang, Hwang-Phill Kim, Hoon Jang, Hyojun Han, Hyoki Kim, Min Jung Kim, Kyung-Hun Lee, Seung-Bum Ryoo, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Sae-Won Han, Tae-You Kim
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Circulating tumor DNA (ctDNA) may reveal dynamic tumor status during therapy. We conducted serial ctDNA analysis to investigate potential association with clinical outcome in metastatic colorectal cancer (mCRC) patients receiving chemotherap
Externí odkaz:
https://doaj.org/article/743bbc06cf9748eeaadef63b4ff5bb41
Autor:
Chiun Hsu, Michel Ducreux, Andrew X. Zhu, Shukui Qin, Masafumi Ikeda, Tae-You Kim, Peter R. Galle, Richard S. Finn, Ethan Chen, Ning Ma, Youyou Hu, Lindong Li, Ann-Lii Cheng
Publikováno v:
Liver Cancer (2022)
Introduction: In the Phase 3 IMbrave150 trial (NCT03434379), atezolizumab + bevacizumab demonstrated a clinically meaningful survival benefit over sorafenib in patients with unresectable hepatocellular carcinoma (HCC), including those with hepatitis
Externí odkaz:
https://doaj.org/article/b9a0faf9c9a043ee9b76567a5b82f791
Autor:
Seung-Hwan Jeong, Dongsoo Kyung, Hyeong Dong Yuk, Chang Wook Jeong, Wookjae Lee, Jung-Ki Yoon, Hwang-Phill Kim, Duhee Bang, Tae-You Kim, Yoojoo Lim, Cheol Kwak
Publikováno v:
Cancers, Vol 15, Iss 10, p 2847 (2023)
Traditional tissue-based assessments of genomic alterations in castration-resistant prostate cancer (CRPC) can be challenging. To evaluate the real-world clinical utility of liquid biopsies for the evaluation of genomic alterations in CRPC, we preemp
Externí odkaz:
https://doaj.org/article/b56035f057454721bd2a0e5cb2624b1b
Autor:
Hye Eun Park, Seung-Yeon Yoo, Nam-Yun Cho, Jeong Mo Bae, Sae-Won Han, Hye Seung Lee, Kyu Joo Park, Tae-You Kim, Gyeong Hoon Kang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Several studies have reported that the prognostic effect of KRAS mutations on colorectal cancers (CRCs) varies depending on the type of mutation. Considering the effect of KRAS mutations on tumor microenvironment, we analyzed the prognostic
Externí odkaz:
https://doaj.org/article/758520450d43498cae6072e4621baaf6